par Da Costa Pereira Pinto, Ana Catarina 
;Ades Moraes, Felipe ;de Azambuja, Evandro ;Piccart-Gebhart, Martine
Référence Breast, 22, S2, page (S152-S155)
Publication Publié, 2013-08
;Ades Moraes, Felipe ;de Azambuja, Evandro ;Piccart-Gebhart, Martine Référence Breast, 22, S2, page (S152-S155)
Publication Publié, 2013-08
Article révisé par les pairs
| Titre: |
|
| Auteur: | Da Costa Pereira Pinto, Ana Catarina; Ades Moraes, Felipe; de Azambuja, Evandro; Piccart-Gebhart, Martine |
| Informations sur la publication: | Breast, 22, S2, page (S152-S155) |
| Statut de publication: | Publié, 2013-08 |
| Sujet CREF: | Chirurgie |
| Mots-clés: | Adjuvant treatment |
| Chemotherapy | |
| Early breast cancer | |
| HER-2 positive | |
| Intravenous trastuzumab | |
| Subcutaneous trastuzumab | |
| MeSH keywords: | Adult |
| Aged | |
| Antibodies, Monoclonal, Humanized -- administration & dosage | |
| Breast Neoplasms -- drug therapy -- genetics -- mortality -- pathology | |
| Chemotherapy, Adjuvant | |
| Clinical Trials, Phase II as Topic | |
| Clinical Trials, Phase III as Topic | |
| Combined Modality Therapy | |
| Disease-Free Survival | |
| Dose-Response Relationship, Drug | |
| Drug Administration Schedule | |
| Female | |
| Humans | |
| Infusions, Intravenous | |
| Injections, Subcutaneous | |
| Mastectomy, Segmental -- methods | |
| Middle Aged | |
| Neoplasm Recurrence, Local -- mortality -- pathology -- therapy | |
| Prognosis | |
| Randomized Controlled Trials as Topic | |
| Receptor, ErbB-2 -- drug effects -- genetics -- metabolism | |
| Survival Analysis | |
| Treatment Outcome | |
| Tumor Markers, Biological -- analysis -- genetics | |
| Note générale: | SCOPUS: ar.j |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0960-9776 |
| info:doi/10.1016/j.breast.2013.07.029 | |
| info:pii/S0960977613001641 | |
| info:scp/84884724778 | |
| info:pmid/24074778 |
